AzTrials
AzTrials

Post-Traumatic Stress Disorder in AdolescenceNCT05899322

Adaptation of the PCIP for Spanish Speaking Adolescents and Families

A study testing Primary Care Intervention for PTSD Spanish Speaking Adolescents and Waitlist Treatment as Usual in people with Post-Traumatic Stress Disorder in Adolescence and Post Traumatic Stress Disorder, run by University of California, Los Angeles at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study will implement a brief Post-traumatic Stress Disorder (PTSD) intervention for children, the Primary Care Intervention for PTSD (PCIP) delivered through telehealth (computer or smart phone delivery), to 10 Spanish speaking youth and their families. Read more about this study

Who is it for?
Ages 12 to 22 yearsHealthy volunteers can take part
What is being tested?
Primary Care Intervention for PTSD Spanish Speaking Adolescents and Waitlist Treatment as Usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
12 Jun 2023to 24 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 22 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patient referred to the SHARK Program
  • Patients must be at least 12 years old
  • Screened for probable PTSD on Brief UCLA Reaction Index, or at provider discretion of clinical relevancy.
  • If patient is under 18 years old, the patient's legal guardian is able and willing to provide informed consent for the patient to participate in the study in English or Spanish;
  • Patient is able to complete study activities in English or Spanish.

Who cannot join

  • Suicidal ideation with a plan within the last two weeks or a suicide attempt within the past 30 days;
  • Patient is over the age of 22

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California Los Angeles

    Los Angeles, California, 90095

Other trials in United States

About this study

Official title: Adaptation and Translation of the Primary Care Intervention for PTSD for Spanish Speaking Adolescents and Families

This study will implement a brief Post-traumatic Stress Disorder (PTSD) intervention for children, the Primary Care Intervention for PTSD (PCIP) delivered through telehealth (computer or smart phone delivery), to 10 Spanish speaking youth and their families.

Mixed methods (qualitative and quantitative) randomized pilot feasibility trial (n=10 to treatment and 10 to waitlist control) to refine the intervention, study procedures, and explore effectiveness.

Read more

Following RE-AIM guidelines, the investigators will assess:

Reach: patient participation in intervention delivery (out of all those asked to participate) and retention rate (out of all those who consented to participate and completed at least two intervention sessions) Adoption: patients and their parents/guardians will complete screening and intervention satisfaction ratings.

To understand patient experiences with the intervention and to identify and explain positive or negative treatment mechanisms or effects, the investigators will conduct post-intervention semi-structured interviews with the participating patients, their parents/guardians, and with providers.

This treatment ranges from 1-3 sessions which last 30-50 minutes per session. The first session will cover psychoeducation about PTSD symptoms in children that can be delivered to the parent or both the parent and child. The first session will also teach the parent and child a breathing technique to combat the physiological impact of PTSD in children. The subsequent sessions will be tailored to meet the needs of the child's most distressing PTSD symptom cluster including hyper arousal, negative changes in cognition and mood, avoidance, re-experiencing. Each session contains coping skills that the parent and child can learn together. There is also material for parents to address behavior problems in youth. This treatment will be delivered via telehealth.

All treatment materials have been developed in both Spanish and English.

Being tested
Primary Care Intervention for PTSD Spanish Speaking Adolescents, Waitlist Treatment as Usual
Keywords
Primary Care, PTSD, Post Traumatic Stress Disorder, Randomized Pilot Feasibility Trial, Spanish speaking adaptation
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Primary Care Intervention for PTSD Spanish Speaking AdolescentsBehavioural

    This treatment ranges from 1-3 sessions which last 30-50 minutes per session. The first session will cover psychoeducation about PTSD symptoms in children that can be delivered to the adolescent with optional parent involvement. The first session will also teach the adolescent a breathing technique to combat the physiological impact of PTSD in children. The subsequent sessions will be tailored to meet the needs of the adolescent's most distressing PTSD symptom cluster including hyper arousal, negative changes in cognition and mood, avoidance, re-experiencing. Each session contains coping skills that address the adolescent's symptoms. This treatment will be delivered via telehealth and all materials have been developed in both Spanish and English.

  • Waitlist Treatment as UsualBehavioural

    Will receive treatment as usual at local clinic and are provided information on free or low cost mental health care referrals in the Los Angeles Area.

Study groups in NCT05899322
Study groupRoleWhat they receive
Primary Care Intervention for PTSD (PCIP) Spanish Speaking Adolescents and FamiliesExperimentalThis arm will receive the culturally adapted and translated PCIP intervention lasting from 1-3 weeks, and will complete baseline, post treatment, and 1-month follow up assessments.
Receives: Behavioral: Primary Care Intervention for PTSD Spanish Speaking Adolescents
Waitlist Treatment as UsualActive comparatorReceive standard care treatment and will complete baseline, post treatment, and 1-month follow up assessments, and are offered translated and adapted PCIP treatment after conclusion of the study.
Receives: Behavioral: Waitlist Treatment as Usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PTSD Knowledge

    Changes in levels of PTSD Knowledge measured by the PTSD Knowledge Test (0-14, higher scores indicating more PTSD knowledge)

    Measured: Day 0 baseline, 1 month follow-up

  2. Change in Self-Reported Arousal

    Changes in PTSD related arousal levels measured by the Self-Assessment Manikin (SAM; 0-24, higher scores indicating higher arousal)

    Measured: Day 0 baseline, 1 month follow-up

  3. Intervention Acceptability

    Qualitative interviews will include questions regarding acceptability of treatment including treatment via telehealth and barriers to treatment.

    Measured: post treatment, average 1 month after enrollment

  4. Intervention Engagement

    Data will be collected regarding participant completion of therapy, no show rates, and attendance.

    Measured: post treatment, average 1 month after enrollment

  5. Intervention Implementation

    Study therapists will complete qualitative interviews regarding intervention delivery feasibility and study protocols.

    Measured: post treatment, average 1 month after enrollment

Secondary outcomes (6)
  1. Change in PTSD Symptoms

    Changes in PTSD related symptoms measured by the UCLA Child/Adolescent PTSD Reaction Index for DSM-5 Brief Screen (total 0-44; Higher scores indicate higher likelihood of PTSD and symptom-related distress and impairment

    Measured: Day 0 baseline, 1 month follow-up

  2. Change in Trauma Symptoms

    Changes in trauma related symptoms measured by The Child PTSD Symptom Scale (CPSS-5-SR) Self Report (total 0-80, Higher scores indicated greater symptom severity).

    Measured: Day 0 baseline, 1 month follow-up

  3. Change in Depression Symptoms

    Changes in depression symptoms measured by the Patient Health Questionnaire (PHQ-9;0-27; Higher scores indicate higher symptoms and likelihood of depression)

    Measured: Day 0 baseline, 1 month follow-up

  4. Change in Anxiety Symptoms

    Changes in anxiety symptoms measured by the Revised Children's Anxiety and Depression Scale (RCADS) Self Report (total 0-141, Higher scores indicating higher symptom severity).

    Measured: Day 0 baseline, 1 month follow-up

  5. Change in Functional Impairment

    Changes in functional impairment measured by The Columbia Impairment Scale (C.I.S.; 0-52, Higher scores indicate greater impairment).

    Measured: Day 0 baseline, 1 month follow-up

  6. Change in Substance Use

    Changes in substance use and misuse measured by CRAFFT Adolescent Substance Use Screen (0-9, Higher scores indicate higher risk for substance misuse).

    Measured: Day 0 baseline, 1 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2023
  2. Study start12 Jun 2023 (estimated)
  3. Primary completion24 Jul 2025
  4. Study completion24 Jul 2025

Why it stopped: Begun collaborating with a new community partner and will submit a new study with that partner.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Mixed methods (qualitative and quantitative) randomized pilot feasibility trial (n=10 to treatment and 10 to waitlist control)
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05899322
Sponsor's protocol ID
#22-001744
Status last verified
Aug 2025
First submitted
24 May 2023
Last updated
6 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Primary Care Intervention for PTSD Spanish Speaking Adolescents and Waitlist Treatment as Usual in people with Post-Traumatic Stress Disorder in Adolescence and Post Traumatic Stress Disorder, run by University of California, Los Angeles at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 6 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PTSD Knowledge (time frame: Day 0 baseline, 1 month follow-up). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in